Eventide Asset Management, LLC Global Blood Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $20.1 Million - $34.1 Million	-535,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $8.84 Million - $10.6 Million	168,000 Added 45.78%	535,000 $28.1 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $4.32 Million - $6.39 Million	137,000 Added 59.57%	367,000 $15.1 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $8.74 Million - $11.8 Million	230,000 New	230,000 $8.74 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $5.64 Million - $8.68 Million	-190,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $4.77 Million - $5.9 Million	190,000	190,000 $5.9 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.